Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2019 | Infectious complications of CLL: prevention and treatment

Ben Kennedy • 1 Apr 2019
BSH 2019
Chronic Lymphocytic Leukemia Ibrutinib Rituximab

Ben Kennedy, MB ChB, FRCP(UK), FRCPath, University Hospitals of Leicester NHS Trust, Leicester, tells us about the infectious complications of chronic lymphocytic leykemia (CLL) and the agents commonly used to treat it, highlighting what can be done to both avoid and address these issues. This interview took place at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK.

More from Ben Kennedy

4:03
Communication between CLL patients and doctors
Ben Kennedy • 1 Apr 2019

Related Videos

3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
3:18
A Phase I study of JBH492, an anti-CCR7 antibody-drug conjugate, in lymphoid malignancies
Pau Abrisqueta • 5 Apr 2024
0:44
Early detection and interception across hematological cancers
Irene Ghobrial • 8 Apr 2024
1:21
Monoclonal B-cell lymphocytosis: a disease to be (or not to be)
Paolo Ghia • 7 Apr 2024
The content of VJHemOnc is intended for healthcare professionals